Envista Holdings Corp
$ 21.71
-0.91%
31 Dec - close price
- Market Cap 3,607,805,000 USD
- Current Price $ 21.71
- High / Low $ 22.01 / 21.70
- Stock P/E 241.22
- Book Value 18.72
- EPS 0.09
- Next Earning Report 2026-02-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.03 %
- ROE N/A %
- 52 Week High 22.68
- 52 Week Low 14.22
About
Envista Holdings Corporation (NVST) is a prominent global player in the dental products and technologies sector, headquartered in Brea, California. Leveraging an expansive portfolio of advanced solutions, Envista enhances dental practices and improves patient outcomes, positioning the company to capitalize on opportunities within the evolving dental market. With a steadfast commitment to quality, continuous innovation, and customer focus, Envista is well-equipped to meet the diverse needs of dental professionals globally. This dedication reinforces its potential for sustained competitive advantage and long-term value creation for institutional investors.
Analyst Target Price
$22.31
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-29 | 2025-07-31 | 2025-05-01 | 2025-02-05 | 2024-10-30 | 2024-08-07 | 2024-05-01 | 2024-02-07 | 2023-11-01 | 2023-08-02 | 2023-05-03 | 2023-02-08 |
| Reported EPS | 0.32 | 0.26 | 0.1 | 0.24 | 0.12 | 0.11 | 0.26 | 0.29 | 0.43 | 0.43 | 0.38 | 0.52 |
| Estimated EPS | 0.28 | 0.23 | 0.04 | 0.22 | 0.09 | 0.28 | 0.32 | 0.34 | 0.46 | 0.41 | 0.41 | 0.49 |
| Surprise | 0.04 | 0.03 | 0.06 | 0.02 | 0.03 | -0.17 | -0.06 | -0.05 | -0.03 | 0.02 | -0.03 | 0.03 |
| Surprise Percentage | 14.2857% | 13.0435% | 150% | 9.0909% | 33.3333% | -60.7143% | -18.75% | -14.7059% | -6.5217% | 4.878% | -7.3171% | 6.1224% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-04 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.32 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NVST
2026-01-01 11:09:19
Envista Holdings (NYSE:NVST) delivered the strongest Q3 performance among tracked dental equipment and technology stocks, beating analyst revenue estimates significantly and achieving the fastest revenue growth. Henry Schein (NYSE:HSIC) and Align Technology (NYSE:ALGN) also reported strong quarters, with their stocks rising after earnings. Dentsply Sirona (NYSE:XRAY), however, had the weakest performance with declining revenues and missed EPS guidance.
2025-12-20 14:09:20
Wall Street Zen has downgraded Envista (NYSE:NVST) from a "strong-buy" to a "buy" rating, though the overall analyst consensus remains a "Hold" with an average price target of $21.77. Despite Envista beating Q3 earnings and revenue estimates, the stock is trading around $22 with a high P/E ratio of 247.47. Several other analysts have also provided varying ratings and price targets for the company recently.
2025-12-19 07:09:29
Envista Holdings (NVST) has seen solid share price gains recently, driven by improving earnings and steady dental equipment demand. While Simply Wall St's narrative pegs the stock as about right in value at $22.15, their DCF model suggests a modest 2.5% undervaluation. Investors should consider potential risks like Chinese pricing reforms, but the company's cost reductions and operational optimizations forecast continued margin improvement.
2025-12-11 15:09:52
DeepCurrents Investment Group LLC significantly reduced its stake in Envista Holdings Corporation (NYSE:NVST) by 99.0% in Q2, now holding 69,831 shares valued at $1.36 million. Envista has a consensus "Hold" rating from analysts with an average price target of $21.54, and the company recently beat earnings estimates with EPS of $0.32 and revenue of $669.9 million. The stock currently trades near its 52-week high, and future analyst forecasts project an EPS of 1 for the current year.
2025-12-10 14:08:40
Stifel has reiterated a Buy rating on Envista Holdings Corp. (NYSE:NVST), citing an improving dental market and the company's strong financial health and aggressive share buybacks. Envista's management describes the market as "stable plus," with accelerated growth in 2025 across clear aligners and diagnostics, and revenue growth of 4.73% over the last twelve months. The company's upbeat outlook is supported by a strong liquidity position and recent positive earnings reports.
2025-12-09 11:21:00
Envista Holdings (NYSE: NVST) shares rose by 3.2% after Barclays initiated coverage with an 'Overweight' rating and a $24 price target, indicating a positive outlook. This new coverage boosted investor confidence, although the stock's volatility suggests the market views this as meaningful but not fundamentally altering its perception of the business. Envista is up 8% year-to-date and is trading near its 52-week high.
